Skip to main content
Retour
Watch Compare

BIOADAPTIVES, INC.

Qualité des données : 100%
BDPT
OTC Manufacturing Chemicals
0,01 €
▲ 0,00 € (10,00%)
Cap. Boursière: 120 086,0
Prix
0,01 €
Cap. Boursière
120 086,0
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue declined -6,14% annually over 5 years
Negative free cash flow of -478 735,0
Revenue growth is decelerating — 1Y growth trails 5Y average by 49,51%

Croissance

Revenue Growth (5Y)
-6,14%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)-55,65%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin-14091,71%
Op. Margin-14410,84%

Sécurité

Debt / Equity
N/A
Current Ratio0,07
Interest Coverage-26,22

Valorisation

PE (TTM)
-0,11
Au-dessus de la moyenne du secteur (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1385 pairs)
Métrique Action Médiane du Secteur
P/E -0,1 -1,5
P/B — 1,6
ROE % — -54,0
Net Margin % -14091,7 -41,5
Rev Growth 5Y % -6,1 1,8
D/E — 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

All Fundamental Metrics
Growth
Revenue Growth (1Y) -55,65% Revenue Growth (3Y) -14,12%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -6,14% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 7 851,0 Net Income (TTM) -1,11 M
ROE N/A ROA -557,53%
Gross Margin 62,59% Operating Margin -14410,84%
Net Margin -14091,71% Free Cash Flow (TTM) -478 735,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,07
Interest Coverage -26,22 Asset Turnover 0,04
Working Capital -1,48 M Tangible Book Value -1,47 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,11 Forward P/E N/A
P/B Ratio N/A P/S Ratio 15,30
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -398,66%
Market Cap 120 086,0 Enterprise Value 120 086,0
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0,00
FCF / Share -0,04 OCF / Share -0,04
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 43,27%
SBC-Adj. FCF -712 405 Growth Momentum -49,51

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 12 669,0 28 565,0 17 176,0 19 776,0 16 327,0
Net Income -899 161,0 -712 466,0 -895 570,0 -1,05 M -847 244,0
EPS (Diluted) — — — — —
Gross Profit 4 030,0 10 819,0 7 126,0 10 105,0 6 095,0
Operating Income -602 090,0 -228 921,0 — — —
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 91 978,0 162 891,0 289 121,0 272 394,0 230 328,0
Income Tax — — 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 261 885,0 103 998,0 37 314,0 148 585,0 18 846,0
Total Liabilities 1,73 M 1,75 M 1,49 M 1,24 M 1,40 M
Shareholders' Equity -1,46 M -1,65 M -1,45 M -1,09 M -1,38 M
Total Debt — — — — —
Cash & Equivalents 261 885,0 60 776,0 25 405,0 — 4 587,0
Current Assets 261 885,0 88 557,0 34 324,0 88 876,0 18 846,0
Current Liabilities 1,73 M 1,75 M 1,49 M 1,24 M 1,40 M